The Influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Hsieh, Ming Chia ^a,b   Lee, Tzu Chi ^c   Cheng, Shu Min ^c   Tu, Shih Te ^a   Yen, Ming Hong ^c   Tseng, Chin Hsiao ^d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COLON CANCER; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN TREATMENT; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; TAIWAN; AGED; MIDDLE AGED; NEOPLASM; REGRESSION ANALYSIS; RISK; SIGNAL TRANSDUCTION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; METFORMIN; MIDDLE AGED; NEOPLASMS; ODDS RATIO; REGRESSION ANALYSIS; RISK; SEX FACTORS; SIGNAL TRANSDUCTION; SULFONYLUREA COMPOUNDS; TAIWAN;

EID: 84863683395     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/413782     Document Type: Article

References (48)

1. Chiang C. J., Chen Y. C., Chen C. J., You S. L., Lai M. S., Cancer trends in Taiwan Japanese Journal of Clinical Oncology 2010 40 10 897 904
2. Tseng C. H., Mortality and causes of death in a national sample of diabetic patients in Taiwan Diabetes Care 2004 27 7 1605 1609
3. El-Serag H. B., Hampel H., Javadi F., The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence Clinical Gastroenterology and Hepatology 2006 4 3 369 380 (Pubitemid 43343895)
4. Coughlin S. S., Calle E. E., Teras L. R., Petrelli J., Thun M. J., Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults American Journal of Epidemiology 2004 159 12 1160 1167 (Pubitemid 38747263)
5. Larsson S. C., Mantzoros C. S., Wolk A., Diabetes mellitus and risk of breast cancer: a meta-analysis International Journal of Cancer 2007 121 4 856 862 (Pubitemid 47106217)
6. Huxley R., Ansary-Moghaddam A., Berrington de Gonzlez A., Barzi F., Woodward M., Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies British Journal of Cancer 2005 92 11 2076 2083 (Pubitemid 40897433)
7. Larsson S. C., Orsini N., Brismar K., Wolk A., Diabetes mellitus and risk of bladder cancer: a meta-analysis Diabetologia 2006 49 12 2819 2823 (Pubitemid 44730282)
8. Larsson S. C., Orsini N., Wolk A., Diabetes mellitus and risk of colorectal cancer: a meta-analysis Journal of the National Cancer Institute 2005 97 22 1679 1687 (Pubitemid 41672234)
9. Tseng C. H., Pioglitazone and bladder cancer: a population-based study of Taiwanese Diabetes Care 2012 35 2 278 280
10. Tseng C. H., Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan Diabetologia 2011 54 8 2009 2015
11. Tseng C. H., Chong C. K., Tseng C. P., Chan T. T., Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan Annals of Medicine 2009 41 5 371 379
12. Tseng C. H., Chong C. K., Tai T. Y., Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006 Diabetologia 2009 52 2 240 246
13. Renehan A. G., Zwahlen M., Minder C., O'Dwyer S. T., Shalet S. M., Egger M., Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis The Lancet 2004 363 9418 1346 1353 (Pubitemid 38529873)
14. Pollak M., Insulin and insulin-like growth factor signalling in neoplasia Nature Reviews Cancer 2008 8 12 915 928
15. Anisimov V. N., Egormin P. A., Bershtein L. M., Zabezhinskii M. A., Piskunova T. S., Popovich I. G., Semenchenko A. V., Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice Bulletin of Experimental Biology and Medicine 2005 139 6 721 723 (Pubitemid 41372239)
16. Schneider M. B., Matsuzaki H., Haorah J., Ulrich A., Standop J., Ding X. Z., Adrian T. E., Pour P. M., Prevention of pancreatic cancer induction in hamsters by metformin Gastroenterology 2001 120 5 1263 1270 (Pubitemid 32246678)
17. Zakikhani M., Dowling R., Fantus I. G., Sonenberg N., Pollak M., Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells Cancer Research 2006 66 21 10269 10273 (Pubitemid 44799743)
18. Buzzai M., Jones R. G., Amaravadi R. K., Lum J. J., DeBerardinis R. J., Zhao F., Viollet B., Thompson C. B., Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth Cancer Research 2007 67 14 6745 6752 (Pubitemid 47105521)
19. Wong A. K. F., Howie J., Petrie J. R., Lang C. C., AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease Clinical Science 2009 116 8 607 620
20. Berstein L. M., Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer Cancer Letters 2005 224 2 203 212 (Pubitemid 40731528)
21. Krentz A. J., Bailey C. J., Oral antidiabetic agents: current role in type 2 diabetes mellitus Drugs 2005 65 3 385 411 (Pubitemid 40227460)
22. Stolar M. W., Hoogwerf B. J., Gorshow S. M., Boyle P. J., Wales D. O., Managing type 2 diabetes: going beyond glycemic control Journal of Managed Care Pharmacy 2008 14 5 S2 S19
23. Lee M. Y., Lin K. D., Hsiao P. J., Shin S. J., The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients Metabolism 2012 61 2 242 249
24. Tseng C. H., Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan Gut 2011 60 6 774 779
25. Foster F., Sex differentials in cancer mortality and morbidity World Health Statistics Quarterly 1978 31 4 360 383
26. Ashley D. J., Sex differences in the incidence of tumours at various sites British Journal of Cancer 1969 23 1 26 30
27. Benigni R., Social sexual inequality and sex difference in cancer incidence Environmental Research 2007 104 1 128 134 (Pubitemid 46560493)
28. Crocetti E., Paci E., What gender differences in cancer incidence changed during the last 10 years in central Italy? Tumori 2002 88 1 13 17 (Pubitemid 34269792)
29. Oksuzyan A., Juel K., Vaupel J. W., Christensen K., Men: good health and high mortality. Sex differences in health and aging Aging Clinical and Experimental Research 2008 20 2 91 102 (Pubitemid 351756761)
30. Wingard D. L., The sex differential in morbidity, mortality, and lifestyle Annual Review of Public Health 1984 5 433 458
31. Barker B. E., Fanger H., Farnes P., Human mammary slices in organ culture. I. Method of culture and preliminary observations on the effect of insulin Experimental Cell Research 1964 35 3 437 448
32. van der Burg B., Rutteman G. R., Blankenstein M. A., De Laat S. W., van Zoelen E. J. J., Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen Journal of Cellular Physiology 1988 134 1 101 108 (Pubitemid 18034935)
33. Goodwin P. J., Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions? Journal of Clinical Oncology 2008 26 6 833 834 (Pubitemid 351398072)
34. Giovannucci E., Michaud D., The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas Gastroenterology 2007 132 6 2208 2225 (Pubitemid 46693749)
35. Tseng C. H., Diabetes and risk of prostate cancer: a study using the National Health Insurance Diabetes Care 2011 34 3 616 621
36. Kasper J. S., Giovannucci E., A meta-analysis of diabetes mellitus and the risk of prostate cancer Cancer Epidemiology Biomarkers and Prevention 2006 15 11 2056 2062 (Pubitemid 44877026)
37. Calton B. A., Chang S. C., Wright M. E., Kipnis V., Lawson K., Thompson F. E., Subar A. F., Mouw T., Campbell D. S., Hurwitz P., Hollenbeck A., Schatzkin A., Leitzmann M. F., History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study Cancer Causes and Control 2007 18 5 493 503 (Pubitemid 46684823)
38. Inoue M., Iwasaki M., Otani T., Sasazuki S., Noda M., Tsugane S., Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan Archives of Internal Medicine 2006 166 17 1871 1877 (Pubitemid 44455170)
39. Khan M., Mori M., Fujino Y., Shibata A., Sakauchi F., Washio M., Tamakoshi A., Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study Asian Pacific Journal of Cancer Prevention 2006 7 2 253 259
40. Waters K. M., Henderson B. E., Stram D. O., Wan P., Kolonel L. N., Haiman C. A., Association of diabetes with prostate cancer risk in the multiethnic cohort American Journal of Epidemiology 2009 169 8 937 945
41. Jee S. H., Ohrr H., Sull J. W., Yun J. E., Ji M., Samet J. M., Fasting serum glucose level and cancer risk in Korean men and women JAMA 2005 293 2 194 202 (Pubitemid 40095870)
42. Koskinen S. V. P., Reunanen A. R. S., Martelin T. P., Valkonen T., Mortality in a large population-based cohort of patients with drug- treated diabetes mellitus The American Journal of Public Health 1998 88 5 765 770 (Pubitemid 28292048)
43. Batty G. D., Shipley M. J., Marmot M., Smith G. D., Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study Cancer Causes and Control 2004 15 9 873 881 (Pubitemid 39663863)
44. Hall G. C., Roberts C. M., Boulis M., Mo J., MacRae K. D., Diabetes and the risk of lung cancer Diabetes Care 2005 28 3 590 594 (Pubitemid 40315318)
45. Currie C. J., Poole C. D., Gale E. A. M., The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 2009 52 9 1766 1777
46. Bowker S. L., Majumdar S. R., Veugelers P., Johnson J. A., Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 2006 29 2 254 258 (Pubitemid 44106500)
47. Tseng C. H., Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study. British Journal of Urology International. In press
48. Lai S. W., Liao K. F., Chen P. C., Tsai P. Y., Hsieh D. P. H., Chen C. C., Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan Clinical Lung Cancer 2012 13 2 143 148